We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Boston Scientific

Boston Scientific is a biomedical/biotechnology engineering company and multinational manufacturer of medical devices... read more Featured Products: More products

Download Mobile App

Next-Gen Insertable Cardiac Monitor Offers Long-Term Monitoring for Arrhythmias

By HospiMedica International staff writers
Posted on 04 Oct 2023
Print article
Image: The LUX-Dx II+ Insertable Cardiac Monitor (ICM) System (Photo courtesy of Boston Scientific)
Image: The LUX-Dx II+ Insertable Cardiac Monitor (ICM) System (Photo courtesy of Boston Scientific)

A next-generation insertable cardiac monitor (ICM) uses enhanced detection algorithms for long-term monitoring of arrhythmias associated with conditions like atrial fibrillation (AF), cryptogenic stroke, and syncope.

Boston Scientific (Marlborough, MA, USA) has launched the LUX-Dx II+ ICM System which features two-stage algorithms to first identify and then confirm potential arrhythmias before sending an alert to healthcare providers. This ensures that the data clinicians receive is both reliable and useful for making treatment decisions. What's more, the device offers remote programming, allowing doctors and healthcare teams to modify detection settings and track symptoms without requiring a face-to-face consultation with the patient.

The dual-stage algorithms in the LUX-Dx II+ ICM System can be configured to spot various types of heart irregularities such as AF, atrial and ventricular tachycardia, bradycardia, and episodes of rhythm pause. These algorithms include a newly added feature for premature ventricular contraction (PVC) burden, designed to recognize arrhythmias whenever preset limits or guidelines are surpassed. The system also employs additional verification filters, including specific settings for nighttime that focus on bradycardia and pause incidents, aiming to eliminate false positives and irrelevant episodes. For enhanced patient experience, the system also offers a new app for easier and more streamlined remote monitoring.

“The LUX-Dx II+ ICM System builds on a strong foundation of cardiac diagnostic technologies at Boston Scientific to provide care teams with the necessary data for critical decision making,” said Scott Olson, senior vice president and president, Cardiac Rhythm Management and Diagnostics, Boston Scientific. “With enhanced and new diagnostic algorithms, physicians will receive timely, accurate and actionable insights to help them make clinically meaningful decisions.”

Related Links:
Boston Scientific

Platinum Supplier
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Specimen Collection & Transport
Ultrasonic Diagnostic System
Gold Supplier
12-Channel ECG

Print article


Surgical Techniques

view channel
Image: A wireless energy-harvesting and storage device (Photo courtesy of Science Advances 2023)

Soft Supercapacitor Could Power Implantable Devices

The field of bioelectronic devices is rapidly advancing, offering new possibilities for health monitoring and the treatment of diseases. A critical aspect of these devices is their power source.... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The patented 3TR technology delivers proven PCR-level sensitivity and specificity (Photo courtesy of 3EO Health)

High-Performing Low-Cost Diagnostic Platform Provides Molecular Results At Near Antigen Pricing

When it comes to point-of-care respiratory diagnostic products, there's often a trade-off between performance and affordability. Current molecular diagnostic solutions are high-performing but expensive... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.